| P2093 | author name string | Qi Dong | |
| | Qingfeng Liu | |
| | Ming Dong | |
| | Qingchang Li | |
| | Dongyang Yu | |
| | Kewei Wang | |
| | Weiwei Sheng | |
| | Junqiang Wang | |
| P2860 | cites work | Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men | Q22242854 |
| | Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies | Q33834445 |
| | Seocalcitol (EB 1089): a vitamin D analogue of anti-cancer potential. Background, design, synthesis, pre-clinical and clinical evaluation | Q33927758 |
| | Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers | Q33942612 |
| | Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy | Q34253198 |
| | Vitamin D, calcium, and retinol intake, and pancreatic cancer in a population-based case–control study in the San Francisco Bay area | Q34407301 |
| | The role of vitamin D in reducing cancer risk and progression | Q34413846 |
| | Vitamin D intake and the risk for pancreatic cancer in two cohort studies | Q34567226 |
| | Aberrant Wnt/beta-catenin signaling in pancreatic adenocarcinoma | Q35081505 |
| | Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma | Q35369888 |
| | Plasma 25-hydroxyvitamin D and risk of pancreatic cancer | Q35661250 |
| | The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. | Q36003426 |
| | Vitamin D receptors and anti-proliferative effects of vitamin D derivatives in human pancreatic carcinoma cells in vivo and in vitro | Q36431217 |
| | A phase II trial of the vitamin D analogue Seocalcitol (EB1089) in patients with inoperable pancreatic cancer | Q36644189 |
| | Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells | Q36683527 |
| | Tumor-stromal interactions in pancreatic cancer | Q36784603 |
| | Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma | Q37351839 |
| | Multiple promoters direct the tissue-specific expression of novel N-terminal variant human vitamin D receptor gene transcripts | Q37473559 |
| | Targeting the β-catenin nuclear transport pathway in cancer | Q38211338 |
| | PI3K/AKT signaling pathway and cancer: an updated review | Q38217651 |
| | Overexpression of calreticulin contributes to the development and progression of pancreatic cancer | Q39058690 |
| | Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States | Q39190004 |
| | Calcitriol enhances gemcitabine anti-tumor activity in vitro and in vivo by promoting apoptosis in a human pancreatic carcinoma model system | Q39668803 |
| | EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation-inducing effects on target cells | Q41673541 |
| | Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. | Q42859934 |
| | Vitamin D receptor is expressed in pancreatic cancer cells and a vitamin D3 analogue decreases cell number | Q44370565 |
| | Vitamins A and D but not E and K decreased the cell number in human pancreatic cancer cell lines | Q45129538 |
| | Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes. | Q53576683 |
| | Low expression of claudin-4 is associated with poor prognosis in esophageal squamous cell carcinoma. | Q54411525 |
| P433 | issue | 3 | |
| P921 | main subject | vitamin D | Q175621 |
| | pancreatic cancer | Q212961 |
| P304 | page(s) | 386-397 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Histopathology | Q1524040 |
| P1476 | title | Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer | |
| P478 | volume | 67 | |